Orchestrated Cytokines Mediated by Biologics in Psoriasis and Its Mechanisms of Action
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Orchestrated Cytokines Mediated by Biologics in Psoriasis and Its Mechanisms of Action
Authors
Keywords
-
Journal
Biomedicines
Volume 10, Issue 2, Pages 498
Publisher
MDPI AG
Online
2022-02-21
DOI
10.3390/biomedicines10020498
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pediatric Psoriasis: From New Insights into Pathogenesis to Updates on Treatment
- (2021) Hye One Kim et al. Biomedicines
- Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches
- (2021) Anna Campanati et al. Biomedicines
- Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis
- (2020) Maria Esposito et al. Expert Review of Clinical Immunology
- Efficacy and Safety of Biologics for Psoriasis and Psoriatic Arthritis and Their Impact on Comorbidities: A Literature Review
- (2020) Masahiro Kamata et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications
- (2020) Esther von Stebut et al. Frontiers in Immunology
- Skin expression of IL-23 drives the development of psoriasis and psoriatic arthritis in mice
- (2020) Lili Chen et al. Scientific Reports
- Evaluation of the effects of IL‑22 on the proliferation and differentiation of keratinocytes in�vitro
- (2020) Le Zhuang et al. Molecular Medicine Reports
- Psoriasis and Antimicrobial Peptides
- (2020) Toshiya Takahashi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Risk of Systemic Diseases in Those with Psoriasis and Psoriatic Arthritis: From Mechanisms to Clinic
- (2020) Yu Ri Woo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The impact of COVID ‐19 in patients with psoriasis: A multicenter study in Istanbul
- (2020) Asude Kara Polat et al. Dermatologic Therapy
- The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
- (2020) Taoming Liu et al. Frontiers in Immunology
- Hectd3 promotes pathogenic Th17 lineage through Stat3 activation and Malt1 signaling in neuroinflammation
- (2019) Jonathan J. Cho et al. Nature Communications
- Modulation of inflammatory gene transcripts in psoriasis vulgaris: Differences between ustekinumab and etanercept
- (2019) Carrie Brodmerkel et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Apoptotic or Antiproliferative Activity of Natural Products against Keratinocytes for the Treatment of Psoriasis
- (2019) Tse-Hung Huang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events
- (2019) Smriti Subedi et al. Drug Design Development and Therapy
- Risk Factors for the Development of Psoriasis
- (2019) Koji Kamiya et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IL-21 Induces an Imbalance of Th17/Treg Cells in Moderate-to-Severe Plaque Psoriasis Patients
- (2019) Yuling Shi et al. Frontiers in Immunology
- Genetic variants within ANRIL (antisense non coding RNA in the INK4 locus) are associated with risk of psoriasis
- (2019) Azadeh Rakhshan et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Gain-of-Function Mutation of Card14 Leads to Spontaneous Psoriasis-like Skin Inflammation through Enhanced Keratinocyte Response to IL-17A
- (2018) Mingchao Wang et al. IMMUNITY
- Melatonin: A Cutaneous Perspective on its Production, Metabolism, and Functions
- (2018) Andrzej T. Slominski et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis
- (2018) Curdin Conrad et al. Nature Communications
- Regulation of IL-22BP in psoriasis
- (2018) Stefanos Voglis et al. Scientific Reports
- The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis
- (2018) Cristina Albanesi et al. Frontiers in Immunology
- Interleukin 23 in the skin: role in psoriasis pathogenesis and selective interleukin 23 blockade as treatment
- (2018) Tom C. Chan et al. Therapeutic Advances in Chronic Disease
- Review of safety and efficacy of approved systemic psoriasis therapies
- (2018) Shivani B. Kaushik et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Psoriasis-Associated Cutaneous Pain: Etiology, Assessment, Impact, and Management
- (2018) DJ Pithadia et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- A Critical Role of the IL-1β-IL-1R Signaling Pathway in Skin Inflammation and Psoriasis Pathogenesis
- (2018) Yihua Cai et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Ixekizumab for the treatment of psoriasis: an update on new data since first approval
- (2018) Christoffer Blegvad et al. Expert Review of Clinical Immunology
- TNF-α Inhibitor-Induced psoriasis: A decade of experience at the Cleveland Clinic
- (2018) Sean E. Mazloom et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Systematic screening and identification of novel psoriasis‑specific genes from the transcriptome of psoriasis‑like keratinocytes
- (2018) Zhen Wang et al. Molecular Medicine Reports
- IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment
- (2018) Laura Mercurio et al. Cell Death & Disease
- RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients
- (2018) Koen Venken et al. Nature Communications
- Psoriasis: Classical vs. Paradoxical. The Yin-Yang of TNF and Type I Interferon
- (2018) Alessio Mylonas et al. Frontiers in Immunology
- Ixekizumab: an anti- IL-17A monoclonal antibody for the treatment of psoriatic arthritis
- (2017) Eric Toussirot EXPERT OPINION ON BIOLOGICAL THERAPY
- Secukinumab in the treatment of psoriasis: an update
- (2017) Radomir Reszke et al. Immunotherapy
- Treatment Approaches to Moderate to Severe Psoriasis
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Old and New Biological Therapies for Psoriasis
- (2017) Kirsten Rønholt et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- β-Defensin 2 is a responsive biomarker of IL-17A–driven skin pathology in patients with psoriasis
- (2017) Frank Kolbinger et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Skin-infiltrating, interleukin-22–producing T cells differentiate pediatric psoriasis from adult psoriasis
- (2017) Kelly M. Cordoro et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study
- (2017) Andrew Blauvelt et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials
- (2017) Kristian Reich et al. LANCET
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Subclinical atherogenesis in patients with mild psoriasis: A role for IL-6?
- (2017) Michelle Larissa Zini Lise et al. Revista da Associacao Medica Brasileira
- Monoclonal antibodies inhibiting IL-12, -23, and -17 for the treatment of psoriasis
- (2017) Caleb Jeon et al. Human Vaccines & Immunotherapeutics
- Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis
- (2017) Jillian Frieder et al. Therapeutic Advances in Chronic Disease
- Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness
- (2017) Ya-Chu Tsai et al. Therapeutic Advances in Musculoskeletal Disease
- IFN-γ and TNF-α synergism may provide a link between psoriasis and inflammatory atherogenesis
- (2017) Nehal N. Mehta et al. Scientific Reports
- Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study
- (2016) D.A. Springate et al. BRITISH JOURNAL OF DERMATOLOGY
- Antimicrobial Peptide LL37 and MAVS Signaling Drive Interferon-β Production by Epidermal Keratinocytes during Skin Injury
- (2016) Ling-juan Zhang et al. IMMUNITY
- CTL-Promoting Effects of IL-21 Counteract Murine Lupus in the Parent→F1 Graft-versus-Host Disease Model
- (2016) Vinh Nguyen et al. JOURNAL OF IMMUNOLOGY
- Therapeutic Elimination of the Type 1 Interferon Receptor for Treating Psoriatic Skin Inflammation
- (2016) Jun Gui et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study
- (2016) A. Chiricozzi et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
- (2016) Kenneth B. Gordon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-17 inhibitors. A new era in treatment of psoriasis and other skin diseases
- (2016) Agnieszka Wasilewska et al. Postepy Dermatologii i Alergologii
- Effect of IL-17 receptor A blockade with brodalumab in inflammatory diseases
- (2016) Ajay Nirula et al. RHEUMATOLOGY
- Molecular and Cellular Profiling of Scalp Psoriasis Reveals Differences and Similarities Compared to Skin Psoriasis
- (2016) Juan Ruano et al. PLoS One
- Psoriasis: classical and emerging comorbidities
- (2015) Maria de Fátima Santos Paim de Oliveira et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial
- (2015) K. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Cytokines in psoriasis
- (2015) Jaymie Baliwag et al. CYTOKINE
- An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17
- (2015) Lynda Grine et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Small Molecules in the Treatment of Psoriasis
- (2015) Tiago Torres et al. DRUG DEVELOPMENT RESEARCH
- Poor adherence to medication as assessed by the Morisky Medication Adherence Scale-8 and low satisfaction with treatment in 237 psoriasis patients
- (2015) Hidehisa Saeki et al. JOURNAL OF DERMATOLOGY
- Efficacy and Safety of Systemic Long-Term Treatments for Moderate-to-Severe Psoriasis: A Systematic Review and Meta-Analysis
- (2015) Alexander Nast et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis
- (2015) Kenneth B. Gordon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci
- (2015) Lam C. Tsoi et al. Nature Communications
- Comparative and Evolutionary Analysis of the Interleukin 17 Gene Family in Invertebrates
- (2015) Xian-De Huang et al. PLoS One
- TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants – past, present and future
- (2014) Lisa M. Sedger et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Role of IL-23 in the pathogenesis of psoriasis: a novel potential therapeutic target?
- (2014) Andrea Chiricozzi et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The role of IL-17 in psoriasis
- (2014) Mona Malakouti et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- A pilot study on the Psoriasis Area and Severity Index (PASI) for small areas: Presentation and implications of the Low PASI score
- (2014) M. E. Otero et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Gene Expression Profiles Normalized in Psoriatic Skin by Treatment with Brodalumab, a Human Anti-IL-17 Receptor Monoclonal Antibody
- (2014) C. B. Russell et al. JOURNAL OF IMMUNOLOGY
- IL-17A Influences Essential Functions of the Monocyte/Macrophage Lineage and Is Involved in Advanced Murine and Human Atherosclerosis
- (2014) Christian Erbel et al. JOURNAL OF IMMUNOLOGY
- IL-36 Promotes Myeloid Cell Infiltration, Activation, and Inflammatory Activity in Skin
- (2014) A. M. Foster et al. JOURNAL OF IMMUNOLOGY
- Genetic Variants of the IL22 Promoter Associate to Onset of Psoriasis before Puberty and Increased IL-22 Production in T Cells
- (2014) Pernilla Nikamo et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- TNF-α Gene Polymorphisms: Association with Disease Susceptibility and Response to Anti-TNF-α Treatment in Psoriatic Arthritis
- (2014) Giuseppe Murdaca et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α
- (2014) David J. Shealy et al. mAbs
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-6 as a Druggable Target in Psoriasis: Focus on Pustular Variants
- (2014) Andrea Saggini et al. Journal of Immunology Research
- Biomarkers in psoriasis and psoriatic arthritis
- (2013) Federica Villanova et al. ANNALS OF THE RHEUMATIC DISEASES
- Serum Cytokines Correlated with The Disease Severity of Generalized Pustular Psoriasis
- (2013) Masaaki Yamamoto et al. DISEASE MARKERS
- IL-22, not simply a Th17 cytokine
- (2013) Sascha Rutz et al. IMMUNOLOGICAL REVIEWS
- Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis
- (2013) Bruce W. Kirkham et al. IMMUNOLOGY
- Keratinocyte Overexpression of IL-17C Promotes Psoriasiform Skin Inflammation
- (2013) A. Johnston et al. JOURNAL OF IMMUNOLOGY
- Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies
- (2013) P.L. Mattei et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Therapeutic opportunities of the IL-22–IL-22R1 system
- (2013) Robert Sabat et al. NATURE REVIEWS DRUG DISCOVERY
- Gene polymorphisms that can predict response to anti-TNF therapy in patients with psoriasis and related autoimmune diseases
- (2013) R Prieto-Pérez et al. PHARMACOGENOMICS JOURNAL
- Associations between Tumor Necrosis Factor-α Polymorphisms and Risk of Psoriasis: A Meta-Analysis
- (2013) Le Zhuang et al. PLoS One
- Serum and tissue levels of IL-17 in different clinical subtypes of psoriasis
- (2012) Senem Buyukkara Yilmaz et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis
- (2012) James G. Krueger et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice
- (2012) Stanislav Pantelyushin et al. JOURNAL OF CLINICAL INVESTIGATION
- IFN-α Enhances IL-22 Receptor Expression in Keratinocytes: A Possible Role in the Development of Psoriasis
- (2012) Mikiko Tohyama et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- CD8+ T Cells in the Lesional Skin of Atopic Dermatitis and Psoriasis Patients Are an Important Source of IFN-γ, IL-13, IL-17, and IL-22
- (2012) DirkJan Hijnen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings
- (2012) David A. Martin et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The development and fate of follicular helper T cells defined by an IL-21 reporter mouse
- (2012) Katja Lüthje et al. NATURE IMMUNOLOGY
- Targeting IL-17 and TH17 cells in chronic inflammation
- (2012) Pierre Miossec et al. NATURE REVIEWS DRUG DISCOVERY
- Psoriasis
- (2011) Gayathri K. Perera et al. Annual Review of Pathology-Mechanisms of Disease
- Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials
- (2011) K. Reich et al. BRITISH JOURNAL OF DERMATOLOGY
- Recent advances in the IL-17 cytokine family
- (2011) Sarah L Gaffen CURRENT OPINION IN IMMUNOLOGY
- Interleukin-17C Promotes Th17 Cell Responses and Autoimmune Disease via Interleukin-17 Receptor E
- (2011) Seon Hee Chang et al. IMMUNITY
- Molecular interactions within the IL-6/IL-12 cytokine/receptor superfamily
- (2011) Lindsay L. Jones et al. IMMUNOLOGIC RESEARCH
- IL-1F5, -F6, -F8, and -F9: A Novel IL-1 Family Signaling System That Is Active in Psoriasis and Promotes Keratinocyte Antimicrobial Peptide Expression
- (2011) A. Johnston et al. JOURNAL OF IMMUNOLOGY
- IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens
- (2011) Xinyang Song et al. NATURE IMMUNOLOGY
- IL-17C regulates the innate immune function of epithelial cells in an autocrine manner
- (2011) Vladimir Ramirez-Carrozzi et al. NATURE IMMUNOLOGY
- Psoriasis in children: An insight
- (2011) Sandipan Dhar et al. INDIAN JOURNAL OF DERMATOLOGY
- Involvement of IL-17F via the induction of IL-6 in psoriasis
- (2010) Sawa Fujishima et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-α levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy
- (2010) S. Coimbra et al. BRITISH JOURNAL OF DERMATOLOGY
- Innovative Uses of Tumor Necrosis Factor α Inhibitors
- (2010) Joni Mazza et al. DERMATOLOGIC CLINICS
- Psoriasis: depression, anxiety, smoking, and drinking habits
- (2010) Jennifer Hayes et al. Dermatologic Therapy
- Angiogenesis drives psoriasis pathogenesis
- (2010) Regina Heidenreich et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Expression of Costimulatory TNFR2 Induces Resistance of CD4+FoxP3- Conventional T Cells to Suppression by CD4+FoxP3+ Regulatory T Cells
- (2010) X. Chen et al. JOURNAL OF IMMUNOLOGY
- Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis
- (2010) Andrea Chiricozzi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Biological therapy of psoriasis
- (2010) Emanual Maverakis et al. INDIAN JOURNAL OF DERMATOLOGY
- Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin
- (2009) C. Johansen et al. BRITISH JOURNAL OF DERMATOLOGY
- Heterogeneity and plasticity of T helper cells
- (2009) Jinfang Zhu et al. CELL RESEARCH
- Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor
- (2009) Zehra Kaymakcalan et al. CLINICAL IMMUNOLOGY
- Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes
- (2009) Lisa C. Zaba et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Population Pharmacokinetics of Golimumab, an Anti-Tumor Necrosis Factor-α Human Monoclonal Antibody, in Patients With Psoriatic Arthritis
- (2009) Zhenhua Xu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Differential Effect of IL-27 on Developing versus Committed Th17 Cells
- (2009) M. El-behi et al. JOURNAL OF IMMUNOLOGY
- Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis
- (2009) Erin G. Harper et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Intravitreal Anakinra Inhibits Choroidal Neovascular Membrane Growth in a Rat Model
- (2009) Jeffrey L. Olson et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
- (2007) Daniel Tracey et al. PHARMACOLOGY & THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now